Description
The goal of this proposal is to describe, compare, andexplain variations in Lynch syndrome (LS) screening implementation acrossmultiple healthcare systems and create a comprehensive, customizableorganizational toolkit for implementing LS screening.
PI is Alanna K. Rahm, PhD,MS, LGC, Geisinger Medicine Institute. Site PI is Su-Ying Liang, Ph.D. Collaborating sites include the following:
Andrea N. Burnett-Hartmann, Ph.D.,MPH, Kaiser Permanente Colorado; Mara Epstein, Sc.D., MeyersPrimary Care; Jessica Enzell Hunter, Ph.D., KaiserPermanente Northwest; Christine Y. Lu, Ph.D., HarvardPilgrim Health Care Institute; Pamala Palowski, Pharm.D., HealthPartners; Ravi Sharaf, M.D., NorthwellHealth; and Robert Weil, M.D., Catholic HealthInitiatives.
Principal Investigator
External PI, Principal Investigator, Su-Ying Liang, Ph.D.
Funder
National Cancer Institute
Start Date
August 01, 2017
End Date
July 31, 2022
Related Studies
Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions
Investigator(s): Su-Ying Liang, Ph.D.
Genetics and Comorbidity of Migraine
Investigator(s): Alice R. Pressman, Ph.D., M.S.
Precision Medicine for Multiple Sclerosis: Making It Work (MS-SHARE)
Investigators: J.B. Jones, PhD, MBA, Xiaowei (Sherry) Yan, PhD, MS
Risk-Benefit Trade-Offs for Whole Genome Sequencing
Investigators: Harold (Hal) Luft, Ph.D., Su-Ying Liang, Ph.D., External PI, Principal Investigator